Sanofi's acquisition of Vigil Neuroscience clears HSR waiting period; special meeting set for Aug 4

Vigil Neuroscience, Inc.

HSR waiting period for Sanofi's acquisition expired July 16, 2025, clearing antitrust condition.
Merger completion still subject to stockholder approval at special meeting on August 4, 2025, and other customary conditions.
Vigil Neuroscience previously entered merger agreement with Sanofi; transaction expected to close after conditions met.

item 8.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.